Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase 1 trial (Annals of Neurology (2007) (399-495))

Amit Bar-Or, Peter A.J. Calabresi, Douglas Arnold, Clyde Markowitz, Stuart Shafer, Lloyd H. Kasper, Emmanuelle Waubant, Suzanne Gazda, Robert J. Fox, Michael Panzara, Neena Sarkar, Sunil Agarwal, Craig H. Smith

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Number of pages1
JournalAnnals of neurology
Issue number6
StatePublished - Jun 1 2008
Externally publishedYes

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this